- Treatment of CMV retinitis in pts with AIDS.
- Approval is based on three Phase II/III trials.
- The safety and efficacy of the drug have not been proven for CMV-related pneumonia, GI disease, congenital infection or neonatal disease. It also has not garnered approval for use in non-HIV infected persons.
NON-FDA APPROVED USES
There's more to see -- the rest of this topic is available only to subscribers.